A new vaccine which may be capable of halting cancer has been manufactured in the labs at the Prague Motol Hospital for a year, local daily Mlada Fronta Dnes reported Sunday, according to Xinhua.
The vaccine is useful in the fight against a number of tumors, and it does not have any such side-effects as chemotherapy has, the daily cited a report published by prestigious medical journal Clinical Immunology.
"Now we are drafting a request for clinical tests," Jirina Bartunkova, a leading researcher, was quoted as saying.
The vaccine, which was developed by a unique method that the Czechs had worked for ten years, can be used in the treatment of melanoma, leukemia, bowel cancer, ovary cancer and recurring tumors, the paper wrote.
One vaccine is sufficient for one patient for a year, and the treatment costs about 100,000 crowns (5,000 U.S. dollars) per year, Bartunkova said.
However, using the vaccine to cure patients is very demanding in terms of time and equipment, and only one vaccine a week can be manufactured in the super pure labs.
"We are able to produce some 50 vaccines a year. However, the research has reached the stage in which the production of the vaccine can be made on a large scale," Bartunkova said.
The research group is negotiating with a biotechnological firm on the production of the vaccine, said the daily.
...